https://www.selleckchem.com/pr....oducts/Rapamycin.htm
Although most massive transfusion protocols incorporate cryoprecipitate in the treatment of hemorrhaging injured patients, minimal data exist on its use in children, and whether its addition improves their survival is unclear. To determine whether cryoprecipitate use for injured children who receive massive transfusion is associated with lower mortality. This retrospective cohort study included injured patients examined between January 1, 2014, and December 31, 2017, at one of multiple centers across the US and Canada participating in
Like
Comment
Share
